Campbell, Christine
Mayo Clinic
Frontier Science Scotland, Kingussie, United Kingdom;
Citations 1
Pregnancies during and following trastuzumab (T) and/or lapatinib (L) in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
Martel, Samuel , Campbell, Christine , Hilbers, Florentine , Schuehly, Uwe, Korde, Larissa A. , Azim, Hatem A. , Tenglin, Richard C., Huober, Jens , Baselga, José , Moreno‐Aspitia, Alvaro , Piccart, Martine , Gelber, Richard D. , Lambertini, Matteo , Campbell, Christine, Guillaume, Sébastien , Cosimo, Serena Di , Azambuja, Evandro de , Ignatiadis, Michail
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10065-10065
